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Localized Proton MRS of the Human Hippocampus:
Metabolite Concentrations and Relaxation Times
Choong Gon Choi and Jens Frahm*
Absolute concentrations and proton relaxation times of major
metabolites in the human hippocampus were determined with
use of fully relaxed, short-echo time STEAM localization se-
quences at 2.0 T (20 normal adults). Mean metabolite concentra-
tions were 7.6 6 0.9 mM for total N-acetylaspartate (tNAA), 6.9 6
0.8 mM for total creatine (tCr), 2.1 6 0.3 mM for choline-
containing compounds (Cho), and 6.2 6 0.9 mM for myo-inositol
(Ins). The observation of relatively low tNAA and high Cho and
Ins levels compared with cortical gray and white matter corre-
sponds to a lower neuronal density and higher glial density than
in the neocortex, in agreement with histologic findings. The data
do not support a lateralization of metabolites. T1 and T2
relaxation times were in the range of 1400–1730 and 140–330
msec, respectively, similar to those in other brain regions. Magn
Reson Med 41:204–207, 1999. r 1999 Wiley-Liss, Inc.
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THE HIPPOCAMPUS and parahippocampal gyrus are im-
portant anatomical structures involved in various disease
processes such as Alzheimer’s disease, schizophrenia,
limbic or herpetic encephalitis, and temporal lobe epilepsy
(TLE). In particular, the pathogenesis of TLE reveals a
characteristic topographic pattern of neuronal loss and
gliosis (1) that has been addressed by in vivo proton
magnetic resonance spectroscopy (MRS) of metabolites
such as total N-acetylaspartate (tNAA), total creatine (tCr),
and choline-containing compounds (Cho) in hippocampal
areas of TLE patients (2–8). So far, however, most studies
were performed at long echo times, and, except for two
reports using the possibly altered water signal as an
internal reference (4,7), the spectroscopic information was
evaluated only as relative ratios of metabolite resonance
signals, i.e. NAA/Cr, NAA/Cho, or NAA/(Cr 1 Cho).
Because the availability of absolute metabolite concentra-
tions allows an assessment of individual metabolites in
direct relation to those of age-matched controls, i.e., inde-
pendent of relative changes and hemispheric comparisons,
the primary aim of the present study was to extend
previous work on quantitative proton MRS of other brain
regions (9) to hippocampal areas. Specific problems arise
from the small volume of the hippocampus and the pres-
ence of strong susceptibility differences between the ante-
rior temporal lobe and surrounding air cavities within the
sphenoid sinus and petrous bone. We therefore first identi-
fied the experimental conditions under which reliable
short-echo-time proton MR spectra of reasonable quality
may be obtained, and in a second step, used such condi-
tions to determine absolute metabolite concentrations as
well as T1 and T2 relaxation times of respective proton
resonances.
MATERIALS AND METHODS
A total of eight subjects participated in a pilot study to
determine the optimum location and size of a volume of
interest (VOI) in the hippocampus. The main study con-
sisted of bilateral investigations of hippocampal areas in 25
healthy volunteers (11 female/14 male; age range 22–43
years, mean 30 6 6 years). In all cases informed written
consent was obtained before the examinations. The sub-
jects’ handedness was determined by asking for the pre-
ferred hand for writing, drawing, and throwing; the pre-
ferred foot for kicking; and the preferred eye for telescope
viewing following the questionnaire in Bernard et al (10).
Proton MRS was conducted at 2.0 T (Siemens Magnetom
Vision, Erlangen, Germany) using the standard headcoil.
The volunteers were positioned with the neck slightly
hyperextended to align the long axis of the hippocampus
proper with the transverse direction. Fully relaxed, short-
echo-time proton MR spectra were recorded with use of a
STEAM sequence (TR/TE/TM 6000/20/10 msec, 64 accu-
mulations) and VOIs ranging from 2.2 to 8.0 mL. The time-
domain data were corrected for residual phase distortions and
calibrated in proportion to the actual coil loading (9).
Automated quantitation of absolute metabolite concentra-
tions was accomplished by LCModel (11). Concentrations
are expressed as mM, i.e., mmol/liter VOI, and are not
corrected for residual T2 relaxation effects and CSF contri-
butions, which were estimated to approximately 5–10%.
T1 saturation was ignored because of a sufficiently long
repetition time. Because of limited spectral resolution in
hippocampal areas, N-acetyl compounds are given as total
NAA (tNAA), i.e., the sum of N-acetylaspartylglutamate
(NAAG) and NAA. Accordingly, total Cr (tCr) represents
both creatine (Cr) and phosphocreatine (PCr). The level of
choline-containing compounds (Cho) predominantly re-
flects contributions from glycerophosphorylcholine (GPC)
and phosphorylcholine (PCh). Complementary to the role
of tNAA as a marker of viable neurons (12), myo-inositol
(Ins) distinctly indicates glial cells (13). Interindividual
hemispheric asymmetry was assessed by comparing mean
concentrations from right and left hippocampal areas
averaged across subjects (two-sided unpaired t-test assum-
ing unequal variances).
Estimates of T1 and T2 relaxation times of major metabo-
lite resonances were obtained from a subgroup of eight
subjects using three differently T1- or T2-weighted spectra.
T1 weighting was achieved by varying the TR from 1500 to
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3000 and 6000 msec (TE/TM 20/10 msec), whereas T2
weighting was based on echo times TE of 20, 135, and 270
msec (TR/TM 6000/10 msec). Assuming monoexponential
relaxation, T1 and T2 values were calculated from the
LCModel analysis of only the singlet resonances of tNAA,
tCr, Cho, and Ins using either a nonlinear Gauss-Newton
method (for T1) or a linear least-squares fitting procedure
(for T2).
RESULTS
Taking both anatomical and technical issues into account,
the size and shape of the hippocampal VOI was optimized
as a rectangular box of dimensions 13 3 18 3 23 mm3 (5.4
mL), as shown in Fig. 1. Special care was taken to avoid
susceptibility effects, to cover most of the hippocampus,
and to minimize partial volume effects with other tissues.
The resulting VOI consisted mainly of the head and body
portions of the hippocampus, parahippocampal gyrus, and
small amounts of perihippocampal white matter and cere-
brospinal fluid (CSF). The anterior medial temporal lobe
containing the uncus, amygdala, and hippocampal heads
was neglected because of its considerable sensitivity to
susceptibility differences, which resulted in low spectral
quality and poor reproducibility. Despite these precau-
tions, Fig. 2 demonstrates that residual uncompensated
susceptibility effects yield hippocampal spectra with
broader resonance linewidths (5.1–6.8 Hz for tCr at 2.0 T)
than obtained in cortical gray and white matter (3.3–4.1
Hz); see Pouwels and Frahm (9).
Table 1 summarizes the hippocampal concentrations of
tNAA, tCr, Cho, and Ins averaged across 20 subjects and
both hemispheres (mean value 6 SD, n 5 40). Further
concentrations may be obtained from an LCModel analysis
of the sum of all 40 spectra exhibiting a largely improved
signal-to-noise ratio for the determination of less concen-
trated metabolites. This strategy yielded 7.1 mM for gluta-
mate, 4.7 mM for glutamine, and 0.6 mM for lactate. The
data from 5 of the 25 subjects were disregarded because
LCModel estimated an uncertainty of the evaluated concen-
trations of more than 10% SD for NAA, Cr, and Cho or more
than 15% SD for Ins in either hemisphere. In these cases
the underlying poor spectral resolution was not caused by
any external factors such as metallic dental prothesis, but
must be ascribed to intrinsic structural inhomogeneities in
and around the hippocampal areas. Both the short-term
reproducibility (i.e., within one examination) or long-term
reproducibility of data acquisition and evaluation (i.e.,
between several examinations) yielded 3–8% SD for tNAA,
tCr, and Cho and 11% SD for Ins.
The data in Table 1 were pooled for both hemispheres
because a statistical analysis of the interindividual asymme-
try did not support any lateralization of metabolite levels
(P . 0.05, n 5 20). More specifically, there was no statisti-
cally significant interindividual asymmetry in a subgroup
of subjects with a right-sided preference in at least four of
FIG. 1. a–c: T1-weighted MR images showing a typical VOI
(13 3 18 3 23 mm3 5 5.4 mL) selected for proton MRS of the
human hippocampus (RF spoiled 3D FLASH, TR/TE 15/6 msec, flip
angle 20°).
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five items of the handedness questionnaire (P . 0.05,
n 5 16, right dominancy).
The T1 and T2 relaxation times of proton resonances of
hippocampal metabolites given in Table 1 are in general
agreement with previous findings in other brain regions,
e.g., compare Kreis (14). Despite the large experimental
uncertainties, the data suggest the absence of major regional
differences. To our knowledge, metabolite relaxation times of
hippocampal areas have not been reported so far.
DISCUSSION
Although the optimization of a single VOI for proton MRS
of hippocampal areas includes minor contributions from
perihippocampal white matter and CSF, the chosen ap-
proach establishes a practical protocol for future studies of
patients with TLE that (a) minimizes examination times,
(b) allows for simple, fast, and fully automated data
evaluation, and (c) provides a maximum of clinically
useful information.
In comparison to a methodologically identical study (9),
the hippocampal tNAA level of 7.6 6 0.9 mM is signifi-
cantly lower than those in frontal, parietal, and occipital
white matter (9.6–10.6 mM), gray matter (8.4–10.6 mM),
cerebellum (8.7–11.0 mM), and thalamus (10.5 mM). Puta-
tively larger contributions from CSF are unlikely to ac-
count for this observation because similar findings apply to
the previous work. Relatively low tNAA in the medial
temporal lobe compared with thalamus or frontal white
matter has also been reported in another single-voxel MRS
study (4) and explains the decrease of the tNAA/Cr inten-
sity ratio with decreasing voxel size (6). In contrast, much
higher absolute tNAA levels of 11–12 mM (4,7) may be
explained by differences in quantitation using water as an
internal reference. This is further supported by the fact that
these studies find much higher values for all other metabo-
lites as well, which limits their usefulness for a detailed
comparison with present results.
Taking tNAA as a neuronal marker and its concentration
as an indicator of neuronal density (12,15), the lower tNAA
content than in neocortex is in good agreement with
reduced neuronal densities reported for the hippocampus
and parahippocampal gyrus from embryologic and histo-
logic evidence (16). Unlike the six-layered neocortex of the
cerebrum, the hippocampus is phylogenetically the oldest
cortex (‘‘archicortex’’), consisting of only a thick superfi-
cial molecular layer, a pyramidal neuron layer, and a
cell-sparse polymorphic layer. Already at the end of 9
gestational weeks, a clear morphologic distinction can be
made between the neocortex and archicortex. The dorsome-
dial portion of the fetal cerebral wall, which constitutes the
future archicortex, reveals a thinner ventricular layer (neu-
roblast zone) and a thicker cell-sparse layer than the
adjacent prospective neocortex. The hippocampal pyrami-
dal or polymorphic cell layers correspond to the deeper
layers 5 and 6 of the neocortex, whereas no cell popula-
tions are found that correspond to the superficial layers 2,
3, and 4 of the neocortex.
The hippocampal Cho concentration of 2.1 6 0.3 mM is
significantly higher than in cerebral gray matter (0.9–1.4
mM) or white matter (1.6–1.8 mM) but similar to that of
cerebellum (2.2 mM) (9). Similar findings apply to the Ins
concentration of 6.2 6 0.9 mM, which is higher than in
cerebral gray matter (4.1–4.7 mM) and even cerebellum
(5.6–5.8 mM) (9). In normal adults, regional differences of
Cho and Ins concentrations mainly depend on the cellular
composition of the brain tissue. Detailed studies of cell
type-specific cultures revealed that Cho concentrations in
astrocytes or oligodendrocytes were two to threefold higher
FIG. 2. Localized proton MR spectra of the hippocampus of a young
healthy adult for three different echo times TE of 20, 135, and 270
msec (STEAM, TR/TM 6000/10 msec, 64 accumulations, VOI 5.4
mL). For display purposes only, spectral processing involved zero-
filling to 4 K complex data points (2048 msec), Gaussian filtering
(half-width 317 msec), and manual phase correction.
Table 1
Concentrations and Proton T1 and T2 Relaxation Times of Major











tNAA 7.6 6 0.9 1408 6 253 283 6 62
tCr 6.9 6 0.8 1554 6 317 191 6 43
Cho 2.1 6 0.3 1438 6 365 334 6 106
Ins 6.2 6 0.9 1726 6 512 138 6 14
amM refers to mmol/liter VOI.
bBilateral spectra from 20 subjects.
cBilateral experiments from eight subjects.
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than in neurons (17) and demonstrated that Ins may be
considered a glial (astrocytic) marker that is not present in
neurons (13). Thus, a most likely explanation for the high
Cho and Ins concentrations in hippocampal areas is an
increased glial cell density relative to the cerebrum. This
may especially hold for the thick molecular and polymor-
phic layers with very low neuronal densities and is further
supported by the general finding that the glial density is
roughly inversely proportional to the neuronal density in
cerebral cortex (18).
Because tCr is contained in both hippocampal neurons
and glial cells, the finding of a hippocampal tCr concentra-
tion of 6.9 6 0.8 mM similar to that of cerebral gray matter
(6.4–7.0 mM) (9) suggests a similar overall cell density as in
the neocortex but with more glial cells and less neurons.
One may speculate that the need for large numbers of
astrocytes may be caused by the high energy demand of
hippocampal pyramidal neurons, which have a higher
synaptic density per neuron than other neocortical neu-
rons (19). It is also supported by high amounts of cytosolic
or mitochondrial creatine kinase isoenzymes found in
granular and pyramidal cell layers of the hippocampus
during postnatal development of rats as well as by high
levels of expression of the creatine transporter in the
pyramidal cell layer of adult rat brains (20,21). In humans,
there is even evidence of muscle-type creatine kinase in
pyramidal cells of the hippocampus proper (22).
CONCLUSIONS
Single-voxel short-echo-time proton MRS examinations of
hippocampal areas were successful in about 80% of nor-
mal adults. Whereas T1 and T2 relaxation times of major
brain metabolites are rather similar to those found in other
brain regions, the hippocampus reveals a unique pattern of
metabolite concentrations that is characterized by rela-
tively low levels of tNAA and high levels of Cho and Ins.
These findings are in line with the hippocampal cytoarchi-
tecture and mixture of cell populations consisting of a
lower neuronal density and higher glial density than in
neocortical tissues. Pertinent insights will help to develop
further quantitative proton MRS of patients with TLE toward
its ultimate role as a tool for noninvasive histopathology.
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